Loading clinical trials...
Loading clinical trials...
PMS Study of MicardisPlus Tablet
Conditions
Locations
326
South Korea
Boehringer Ingelheim Investigational Site 10
Busan, South Korea
Boehringer Ingelheim Investigational Site 11
Busan, South Korea
Boehringer Ingelheim Investigational Site 12
Busan, South Korea
Boehringer Ingelheim Investigational Site 13
Busan, South Korea
Boehringer Ingelheim Investigational Site 14
Busan, South Korea
Boehringer Ingelheim Investigational Site 15
Busan, South Korea
Start Date
September 1, 2003
Primary Completion Date
July 1, 2008
Last Updated
June 6, 2014
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions